Comparison of Safety of Subcutaneous Enoxaparin as Outpatient Anticoagulation Bridging Therapy in Patients With a Mechanical Heart Valve Versus Patients With Nonvalvular Atrial Fibrillation
Publication year: 2009<br><b>Source:</b> The American Journal of Cardiology, In Press, Corrected Proof, Available online 26 September 2009<br>Hien Thuy, Bui , Ashok, Krisnaswami , Chieu-Uyen, Le , James, Chan , Bach-Nga, Shenoy<br><br>Patients with mechanical heart valves (MHVs) are at a higher risk for thromboembolic events than patients with atrial fibrillation (AF). This difference is observed in the higher maintenance international normalized ratio (INR) range for patients with MHV and in the selection for anticoagulation bridge therapy when warfarin is interrupted perioperatively. However, once the decision is made to âbridge,â the same therapeutic options, unfractionated